These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32347894)

  • 1. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.
    DeJong C; Wachter RM
    JAMA Intern Med; 2020 Aug; 180(8):1118-1119. PubMed ID: 32347894
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    de Miranda Santos IKF; Costa CHN
    Front Immunol; 2020; 11():1739. PubMed ID: 32849619
    [No Abstract]   [Full Text] [Related]  

  • 3. Internet Searches for Unproven COVID-19 Therapies in the United States.
    Liu M; Caputi TL; Dredze M; Kesselheim AS; Ayers JW
    JAMA Intern Med; 2020 Aug; 180(8):1116-1118. PubMed ID: 32347895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Avidan MS; Dehbi HM; Delany-Moretlwe S
    N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Tekwani BL
    N Engl J Med; 2020 Sep; 383(11):1088-1089. PubMed ID: 32668108
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Khan MS; Butler J
    N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
    [No Abstract]   [Full Text] [Related]  

  • 9. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
    Schluger NW
    Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
    Frigerio M
    Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
    Okafor EC; Pastick KA; Rajasingham R
    N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic].
    Bozzo R; Ibelli F; Scublinsky D
    Medicina (B Aires); 2020; 80 Suppl 3():89-90. PubMed ID: 32658855
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
    Afra TP; T MR; Bishnoi A; Hafi NB
    Lancet Infect Dis; 2020 Oct; 20(10):1120-1121. PubMed ID: 32559452
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence of Protective Effect of Hydroxychloroquine on COVID-19.
    Joob B; Wiwanitkit V
    J Rheumatol; 2020 Oct; 47(10):1587. PubMed ID: 32451353
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine for Treatment of SARS-CoV-2 Infection? Improving Our Confidence in a Model-Based Approach to Dose Selection.
    Arnold SLM; Buckner F
    Clin Transl Sci; 2020 Jul; 13(4):642-645. PubMed ID: 32268005
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
    Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):375-376. PubMed ID: 32740072
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    Thomson K; Nachlis H
    JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
    Paliani U; Cardona A
    Eur J Intern Med; 2020 Oct; 80():121. PubMed ID: 32709544
    [No Abstract]   [Full Text] [Related]  

  • 19. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 20. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
    Wiwanitkit V
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):374. PubMed ID: 32740070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.